URGN
Urogen Pharma Ltd
NASDAQ · Biotechnology
$21.35
+0.83 (+4.04%)
Open$20.68
Previous Close$20.52
Day High$21.77
Day Low$20.68
52W High$30.00
52W Low$3.42
Volume—
Avg Volume684.8K
Market Cap999.37M
P/E Ratio—
EPS$-3.31
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+112.5% upside
Current
$21.35
$21.35
Target
$45.36
$45.36
$37.53
$45.36 avg
$61.85
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 98.69M | 79.93M | 558.77M |
| Net Income | -138,507,519 | -100,969,356 | 35.72M |
| Profit Margin | -140.4% | -133.3% | 6.4% |
| EBITDA | -131,107,032 | -100,884,238 | 53.38M |
| Free Cash Flow | — | — | 30.74M |
| Rev Growth | +23.5% | +23.5% | -6.2% |
| Debt/Equity | — | — | 0.90 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |